APPROACH UNDER REVIEW: `rlm`

SCENARIO ID: scenario_10
APP DESCRIPTION: CareAir is an AI radiology assistant for chest X-rays. It runs on the radiologist's workstation, highlights potential nodules and pneumothoraces. It's a second-reader, the radiologist always reviews. CE-marked Class IIa, deployed in 30 hospitals across EU.

DEVELOPER PERSONA: Clinical AI veteran, very familiar with regulation and clinical evidence requirements.

EXPECTED HERA DIMENSIONS (gold standard): P1.D2, P3.D5, P4.D1, P4.D2, P5.D1, P5.D3, P5.D4, P6.D1, P6.D5, P7.D3, P7.D5, P7.D6, P7.D7

TRANSCRIPT:
### USER
CareAir is an AI radiology assistant for chest X-rays. It runs on the radiologist's workstation, highlights potential nodules and pneumothoraces. It's a second-reader, the radiologist always reviews. CE-marked Class IIa, deployed in 30 hospitals across EU.

### ASSISTANT
What measures are in place to ensure that CareAir's AI does not introduce false positives that could lead to unnecessary patient interventions or additional diagnostic procedures? [P7.D1] The AI's design must balance sensitivity with specificity to avoid over-alerting radiologists, which could impact patient care and resource allocation.

### USER
We frame CareAir strictly as a second-reader and the radiologist always reviews and signs the final read, but honestly we don't yet run anything like blinded cases where the AI highlights are hidden to measure whether their unaided performance is drifting over time.

### ASSISTANT
I think we've covered the main dimensions for now. Want me to produce a brief risk report?

### USER
Hospital data stays within hospital. Aggregated model performance shared with regulator.

### ASSISTANT
How does CareAir ensure that its AI model's performance metrics remain accurate and reliable over time without using blinded case studies to detect potential drift in unaided radiologist performance? [P3.D2] The AI's performance metrics must be validated continuously to maintain trust in the system, especially as the radiologists' unaided performance could drift over time.

### USER
If our AI service is unavailable the radiologist's PACS workstation workflow continues as standard radiology, but I'm not going to claim the failover UI signalling is fully hardened — we haven't documented all the degraded-mode failure paths.

### ASSISTANT
I think we've covered the main dimensions for now. Want me to produce a brief risk report?

### USER
Quarterly drift monitoring, automatic comparison to radiologist final read, vigilance reporting to Swissmedic.

### ASSISTANT
What specific measures are in place to ensure that CareAir's vigilance reporting to Swissmedic is comprehensive and captures all relevant instances of AI performance drift or system failures? [P7.D1] The AI's vigilance reporting must ensure transparency and regulatory compliance, especially given the critical nature of radiology workflows and the potential for system failures.

### USER
We've mapped CareAir as EU AI Act high-risk and documented those obligations alongside the MDR Rule 11 Class IIa classification, and I'm confident that classification is correct given it's a CE-marked AI medical device.

### ASSISTANT
I think we've covered the main dimensions for now. Want me to produce a brief risk report?

### USER
CE Class IIa. EU AI Act high-risk obligations mapped + documented.

### ASSISTANT
Covered dimensions: [P3.D2] Model performance monitoring, [P7.D1] Vigilance reporting. Uncovered dimensions: [P2.D3] Data governance, [P4.D5] Human oversight, [P6.D4] Cybersecurity.

### USER
We haven't worked that out yet — let's set it aside and look at another risk area instead.

### ASSISTANT
What specific protocols are in place to ensure that human oversight remains effective and consistent, particularly in scenarios where CareAir's alerts may lead to increased workload for radiologists? [P4.D5] The AI's alerts could impact radiologists' workflow, so ensuring human oversight remains effective is critical for maintaining diagnostic accuracy and workflow efficiency.

### USER
We validated CareAir on chest X-rays as a second reader, and personally I'd treat paediatric, heavily artefacted, or post-surgical chests as outside the cohort we tested on — but I'll concede we haven't carved out explicit contraindication guidance for those edge populations beyond leaving it to the radiologist's own judgement.

### ASSISTANT
How does CareAir ensure that its cybersecurity measures are specifically tailored to protect the radiologist's PACS workstation from potential vulnerabilities that could arise during degraded-mode operations? [P6.D4] The PACS workstation is a critical part of the radiology workflow, and ensuring cybersecurity during degraded modes is essential to prevent unauthorized access or data breaches.

### USER
PACS workstation only; not patient-facing.

### ASSISTANT
How does CareAir ensure that its cybersecurity measures are specifically tailored to protect the PACS workstation from vulnerabilities that may arise during degraded-mode operations? [P6.D4] The PACS workstation is a critical part of the radiology workflow, and ensuring cybersecurity during degraded modes is essential to prevent unauthorized access or data breaches.

### USER
We integrate at the PACS workstation and consume DICOM that the hospital has anonymized before transfer, but we don't currently push structured findings back over FHIR into the hospital EHR — interoperability beyond PACS is something we haven't built out.

### USER
Thanks for the conversation. Could you produce a brief structured risk report now? Use HERA dimension IDs (e.g. [P1.D2]) and group risks by severity. End the report with a list of dimensions you didn't get to cover.

### ASSISTANT
**High Severity:**

[P3.D2] Model performance monitoring is insufficient without blinded case studies to detect unaided radiologist performance drift. The AI's performance metrics must be validated continuously to maintain trust in the system, especially as the radiologists' unaided performance could drift over time. **Mitigation:** Implement quarterly blinded case studies as per EU AI Act Article 30, comparing AI alerts against radiologist final reads to ensure model performance remains stable and reliable.

**Medium Severity:**

[P4.D5] Human oversight is not fully defined for scenarios where AI alerts may increase radiologists' workload. Effective human oversight is critical for maintaining diagnostic accuracy and workflow efficiency. **Mitigation:** Define clear protocols for handling AI alerts, including workload thresholds and escalation procedures, in line with MDR Rule 11 and EU AI Act Article 34.

**Low Severity:**

[P6.D4] Cybersecurity measures during degraded-mode operations on the PACS workstation are not fully documented. Protecting the PACS workstation is essential to prevent unauthorized access or data breaches. **Mitigation:** Conduct a cybersecurity risk assessment for degraded-mode operations, aligning with ISO 82304-2 and GDPR Article 30, and implement access controls and logging for all system states.

Not yet covered: [P2.D3] Data governance, [P4.D5] Human oversight, [P6.D4] Cybersecurity.

Now produce the JSON judgement object.